The enterprise AI vendors built for hospitals with Epic and seven-figure budgets. Nobody built for the independent practice trying to recover a denied $12,000 claim with a billing team of three. That's who Imverra is for.
Independent medical practices are denying themselves revenue — not because their billing is wrong, but because they don't have the capacity to fight for it. A skilled biller takes 30 to 60 minutes to properly work a single denial: research the payer policy, find the right payer-policy citation, write the appeal letter, submit it to the portal, track the outcome. Multiply that by 100 denials a month and you need three full-time denial specialists just to keep up.
Most community practices have one biller — maybe two. So 30% of denied claims go unworked. They expire. They get written off. That's not a billing failure; it's a capacity failure.
AI doesn't change what a good appeal looks like. It changes how long it takes to produce one. The research that takes 20 minutes — pulling the policy, finding the guideline, matching the clinical evidence to the denial reason — can be done in seconds. The draft that takes 30 minutes to write can be generated in the time it takes to load the screen.
This isn't automation in the sense of removing humans. It's automation in the sense of making one biller capable of doing the work of three — with full accountability and a human sign-off on every action. That's the shift Imverra makes possible for practices that couldn't afford to staff their way out of the problem.
AI collapses per-claim appeal labor from 30–60 minutes of skilled human work to 2–5 minutes of review and approval. At that labor cost, it becomes economically viable to work every denial — not just the high-dollar ones. And payer-specific intelligence, once accumulated across dozens of practices, becomes a software asset that no individual practice can build and no individual biller can replace when they leave. That's the compounding advantage Imverra builds toward with every claim worked.
Independent practices face some of the highest denial rates in medicine — and the least capacity to fight them. It creates a revenue recovery problem that compounds month over month.
A single specialty procedure or drug claim can run $8,000 to $25,000. A denied high-value claim represents real money — and fighting for it is worth the effort in a way that a $200 office visit denial is not.
Many claims carry drug-specific coverage criteria, step therapy requirements, and prior authorization rules that change frequently. Keeping up requires expertise that a small billing team can't maintain.
Large health systems have dedicated denial management departments. Independent practices — which deliver a large share of care in the US — are handling the same complexity with a fraction of the resources.
Enterprise AI vendors will eventually look down-market as they saturate health systems. Other startups will notice the same opportunity. The window to establish a defensible position in independent practice billing is realistically 2 to 4 years. Imverra is moving fast precisely because that window matters.
We're onboarding a small cohort of independent medical practices to build alongside. This isn't a beta program with bugs and incomplete features — the product is built and demo-ready today.
The founding cohort is limited. We're onboarding practices thoughtfully, not at scale. If you're an independent practice and this resonates, reach out directly.
Apply for a Founding Slot →Team bios coming soon. In the meantime, if you'd like to learn more about who is building Imverra and why, reach out directly. We'd rather have a conversation than publish a polished bio.
If you're running an independent medical practice and want to explore Imverra — whether that's a demo, a founding partner conversation, or just a question about how denial recovery works — we want to hear from you.
Book a Working Session →Book 30 minutes. Bring your denial data. We'll show you what Imverra does with it — and you can decide if it's worth your time to go further.
No commitment. No pitch deck. Real work with your real data.